What Does Oak Woods Acquisition (OAKU) Do? — Stock Outlook, Earnings, Market Cap, Related Stocks, and Headquarters Overview
A SPAC (Special Purpose Acquisition Company) targeting acquisitions in Asia-Pacific healthcare companies.
Subscribe🏢 What kind of company is Oak Woods Acquisition?
Oak Woods Acquisition Corporation is a SPAC (Special Purpose Acquisition Company) headquartered in Ontario, Canada. A SPAC is a shell company with no actual operating business; its purpose is to raise funds through an IPO and then acquire or merge with a private company to take it public through a reverse listing. Oak Woods is listed on NASDAQ under the ticker OAKU, with its acquisition target being technology-driven healthcare services companies in the Asia-Pacific region.
💰 How does it make money?
By its nature as a SPAC, it currently generates no operating revenue. The $57.5 million raised through its IPO is deposited into a trust account, where interest is generated. Once a De-SPAC merger is completed, the sponsors (management team) realize returns through the appreciation of founder shares acquired at a discount. If the merger is not completed, the trust funds are returned to shareholders and the company is dissolved. The acquisition target is Huajin (China) Holdings, a non-medical community healthcare services company serving elderly populations in China.
| Item | Details | Notes |
|---|---|---|
| IPO Proceeds | $57.5 million | IPO in March 2023, $10 per share, 5.75 million shares |
| Acquisition Target | Huajin (China) Holdings | Elderly community care services in China, enterprise value of $250 million |
| Merger Deadline | March 28, 2026 | If not completed by the deadline, trust funds will be returned and the company dissolved |
Market Cap and Company Scale
Oak Woods Acquisition's market capitalization stands at $34.5M, roughly About 0% the size of Samsung Electronics' market cap. The company has approximately 1 people employees. Due to its SPAC structure, there is virtually no operational workforce, and the majority of its assets consist of cash held in the trust account. It is currently in an extremely unstable state, having received a NASDAQ delisting notice and being in the process of an appeal.
📈 Oak Woods Acquisition Outlook and Stock Price Trends
1-Year Price Performance
Analyst Consensus
52-Week Price RangeOak Woods Acquisition is facing two major upcoming events: the NASDAQ delisting appeal hearing on March 24, 2026, and the merger completion deadline on March 28, 2026. If the merger goes through, Huajin Holdings will transform into a NASDAQ-listed company, and Oak Woods shareholders will receive shares in the merged entity. The Asia-Pacific healthcare IT market is projected to grow at a CAGR of 17.6% through 2030, indicating strong structural growth potential. However, in the event of a failed merger or delisting, shareholders can still recover the trust funds, though the stock may move to OTC markets or proceed with dissolution procedures.
⚔️ Key Competitive Strengths and Risks
Oak Woods's strength lies in the principal protection structure of its trust account. On the other hand, the NASDAQ delisting threat and the imminent merger deadline pose serious risks.
💪 Key Competitive Strengths
⚠️ Key Risks
Competitors and Related (Beneficiary) Stocks
Competitors include similar companies in the Asia healthcare or SPAC space. Most direct comparable SPACs have already completed their mergers or been liquidated. Chinese healthcare technology companies such as Ich Flex (ACY) and other listed Asia healthcare-related companies serve as indirect comparison points.
Related (beneficiary) stocks include companies operating in the same fields as the merger target, Huajin Holdings—namely elderly community care and smart healthcare. Clover Health (CLOV) is an AI-based elderly medical services company, while Humana (HUM) is a large-cap company specializing in senior health insurance. If the merger succeeds, indirect beneficiaries of growth in the Asia healthcare market are also expected.
Compare real-time quotes and key metrics for competitors and related stocks in the table below.
✅ Investor Checkpoints
Oak Woods Acquisition is a SPAC targeting acquisitions of Asia-Pacific healthcare companies, but it currently faces two major threats: a NASDAQ delisting risk and an imminent merger deadline. SPAC investments have characteristics very different from typical stock investments, so extra caution is warranted.
| Checkpoint | What to Verify | Current Status |
|---|---|---|
| 📊 Merger Progress | Can the Huajin merger be completed by the deadline? | ⚠️ March 28, 2026 deadline; merger completion uncertain |
| 💰 Listing Maintenance | Can the NASDAQ delisting appeal succeed? | ⚠️ Hearing on March 24, 2026; outcome uncertain |
| 🔄 Trust Funds | Can the principal be refunded if the merger fails? | ✅ Approximately $10 per share redemption structure from trust funds |
| ⚡ China Risk | Will deterioration of U.S.-China relations affect the merger? | ⚠️ Ongoing geopolitical uncertainty |
However, SPAC investments can produce vastly different outcomes depending on whether the merger is completed. OAKU currently carries the additional risk of a NASDAQ delisting, making it a highly speculative stock. It is not suitable for investors.
In summary, Oak Woods Acquisition is a SPAC aiming to capitalize on growth in the Asia healthcare market, but it is currently in an extremely uncertain situation due to delisting risk and the looming merger deadline. While the trust fund principal protection provides a downside safety net, investors should fully understand the delisting and merger-failure scenarios before considering exposure.
Check Oak Woods Acquisition's real-time quotes, technical indicators, and peer comparisons at a glance on US Stock Today's real-time dashboard.
Subscribe Today's 5 AI picks, all free